Delivery Order SPE2DB22D1106-SPE2DB24FEBA8
- Not listed
- This federal contract award, with ID SPE2DB22D1002|SPE2DB23FLGF7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with a ceiling value of $5,852.16 and an ultimate completion date of September 15, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for the treatment of opioid overdose. The award has a ceiling value of $1,399.49 and an ultimate completion date of May 19, 2023. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora,...
- This contract award, with a ceiling value of $2,788.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for the treatment of opioid overdose. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November...
- This federal contract award, with ID SPE2DB22D1002|SPE2DB24FKZE7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with a ceiling value of $2,120.19 and a completion date of March 13, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award, with the ID SPE2DB20D2104|SPE2DB24FU00X, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,665.40 delivery order contract is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of May 6, 2024. This award is part of a larger Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with an ultimate completion date of November 2, 2023. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,692.13. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,981.46 and is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,192.67 for 4,559,700,837 units of NARCAN 4 MG NASAL SPRAY 2S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of January 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with a ceiling value of $2,660.96 and a completion date of February 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $10,944.80, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 13, 2024. The contract is not designated with a set-aside requirement, indicating open...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEBA8Delivery Order
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEBA8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with a ceiling value of $2,765.30 and a completion date of February 22, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/21/24 |